semaglutide aion The obesity drug (Wegovy) conferred a significantly higher risk of ischemic optic neuropathy (ION) than any other GLP-1 agonist, including semaglutide for diabetes (Ozempic), an analysis of FDA data showed. Added Semaglutide Vs. Other GLP-1 Drugs

People with hypothyroidism can use GLP-1 medications like semaglutide, but thyroid function requires close monitoring during weight loss treatment

Our capabilities include: High-protein nutritional formulations Muscle preservation and recovery solutions Gastrointestinal support formulations Micronutrient replenishment systems Specialized clinical nutrition products Custom product development for healthcare brands and institutions As GLP-1 therapies continue to evolve, personalized nutrition will become an essential component of patient success

If you're taking a GLP-1, you may not want to take it forever

A shelf-stable GLP-1 probiotic that actually reaches the intestine supports GI balance during treatment.*

California will stop covering GLP-1 drugs like Ozempic and Wegovy through Medi-Cal under its new 202526 budget, citing rising costs and structural reforms